Atomo Diagnostics (ASX:AT1) Interest Expense : A$-0.01 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Atomo Diagnostics's interest expense for the six months ended in Dec. 2024 was A$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Atomo Diagnostics's Operating Income for the six months ended in Dec. 2024 was A$ -3.44 Mil. Atomo Diagnostics's Interest Expense for the six months ended in Dec. 2024 was A$ -0.01 Mil. Atomo Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Atomo Diagnostics Interest Expense Historical Data

The historical data trend for Atomo Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Interest Expense Chart

Atomo Diagnostics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Expense

-5.29

-0.01

-0.02

-0.01

Atomo Diagnostics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial						-0.01	-0.01	-0.01	-	-0.01

Atomo Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01 Mil.

Atomo Diagnostics (ASX:AT1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Atomo Diagnostics's Interest Expense for the six months ended in Dec. 2024 was A$-0.01 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$-3.44 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$0.03 Mil.

Atomo Diagnostics's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Atomo Diagnostics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines